Orchestra BioMed Holdings, Inc. (OBIO) EBITDA
- 2026-06-30: Basis Reported; EBITDA -$22.26M*; Operating income -$22.36M; Depreciation and amortization $96.00K*.
- 2026-03-31: Basis Reported; EBITDA -$21.99M; Operating income (m); Depreciation and amortization (m).
- 2025-12-31: Basis Reported; EBITDA $6.84M; Operating income (m); Depreciation and amortization (m).
- 2025-09-30: Basis Reported; EBITDA -$20.23M*; Operating income -$20.31M; Depreciation and amortization $81.00K*.
Complete source-backed ebitda history.
- Available history
- 2022-03-31 to 2026-03-31
- Data captured
Historical EBITDA
EBITDA 3 month
| Date | Basis | EBITDA | Operating income | Depreciation and amortization | Revenue | EBITDA margin | Capital spending | Operating cash flow | Cost of products and services | Research and development | Selling, general and administration | Income tax expense / benefit |
|---|
| 2026-06-30 | Reported | -$22.26M* | -$22.36M | $96.00K* | (m) | (m) | $254.00K* | -$19.33M* | (m) | $16.59M | $5.83M | (m) |
|---|
| 2026-03-31 | Reported | -$21.99M | (m) | (m) | (m) | -19987.27% | $184.00K | -$22.17M | (m) | $15.78M | $6.37M | (m) |
|---|
| 2025-12-31 | Reported | $6.84M | (m) | (m) | (m) | 22.11% | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2025-09-30 | Reported | -$20.23M* | -$20.31M | $81.00K* | (m) | (m) | $310.00K* | -$14.55M* | (m) | $14.03M | $7.10M | (m) |
|---|
| 2025-06-30 | Reported | -$19.25M* | -$19.33M | $81.00K* | (m) | (m) | $34.00K* | -$15.53M* | (m) | $13.85M | $6.26M | (m) |
|---|
| 2025-03-31 | Reported | -$18.84M | (m) | (m) | (m) | -2170.28% | $112.00K | -$16.62M | (m) | $13.48M | $6.26M | (m) |
|---|
| 2024-12-31 | Reported | -$16.59M | (m) | (m) | (m) | -6558.50% | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2024-09-30 | Reported | -$16.27M* | -$16.34M | $76.00K* | (m) | (m) | $68.00K* | -$13.70M* | (m) | $11.60M | $5.67M | (m) |
|---|
| 2024-06-30 | Reported | -$16.79M* | -$16.86M | $74.00K* | (m) | (m) | $107.00K* | -$10.21M* | (m) | $11.13M | $6.47M | (m) |
|---|
| 2024-03-31 | Reported | -$14.35M | (m) | (m) | (m) | -2314.35% | $8.00K | -$13.11M | (m) | $9.11M | $5.90M | (m) |
|---|
| 2023-12-31 | Reported | -$12.41M | (m) | (m) | (m) | -4736.26% | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2023-09-30 | Reported | -$14.45M* | -$14.52M | $71.00K* | (m) | (m) | $19.00K* | -$10.28M* | (m) | $8.56M | $6.34M | (m) |
|---|
| 2023-06-30 | Reported | -$12.88M* | -$12.96M | $73.00K* | (m) | (m) | $27.00K* | -$10.49M* | (m) | $8.50M | $5.32M | (m) |
|---|
| 2023-03-31 | Reported | -$11.47M | (m) | (m) | (m) | -985.74% | $35.00K | -$14.38M | (m) | $8.25M | $4.41M | (m) |
|---|
| 2022-12-31 | Reported | -$9.76M | (m) | (m) | (m) | -884.68% | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2022-09-30 | Reported | -$10.01M* | -$10.07M | $54.00K* | (m) | (m) | $224.00K* | -$7.26M* | (m) | $5.90M | $5.28M | (m) |
|---|
| 2022-06-30 | Reported | -$7.58M* | -$7.63M | $50.00K* | (m) | (m) | $266.00K* | -$7.96M* | (m) | $5.03M | $2.95M | (m) |
|---|
| 2022-03-31 | Reported | -$5.08M | (m) | (m) | (m) | -586.61% | $47.00K | -$5.32M | (m) | $3.47M | $2.48M | (m) |
|---|
| 2021-09-30 | Reported | (m) | -$94.44K | (m) | (m) | (m) | (m) | -$128.01K* | (m) | (m) | (m) | (m) |
|---|
| 2021-06-30 | Reported | (m) | -$96.32K | (m) | (m) | (m) | (m) | -$39.14K* | (m) | (m) | (m) | (m) |
|---|
| 2021-03-31 | Reported | (m) | -$111.95K | (m) | (m) | (m) | (m) | -$76.37K | (m) | (m) | (m) | (m) |
|---|
| 2020-09-30 | Reported | (m) | -$68.63K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
EBITDA 12 month
| Date | Basis | EBITDA | Operating income | Depreciation and amortization | Revenue | EBITDA margin | Capital spending | Operating cash flow | Cost of products and services | Research and development | Selling, general and administration | Income tax expense / benefit |
|---|
| 2025-12-31 | Reported | -$51.48M | (m) | (m) | (m) | -153.75% | $489.00K | -$48.96M | (m) | $58.19M | $26.91M | $0.00 |
|---|
| 2024-12-31 | Reported | -$63.99M | (m) | (m) | (m) | -2425.82% | $289.00K | -$50.56M | (m) | $42.80M | $23.93M | (m) |
|---|
| 2023-12-31 | Reported | -$51.22M | (m) | (m) | (m) | -1855.76% | $78.00K | -$46.13M | (m) | $33.82M | $20.26M | (m) |
|---|
| 2022-12-31 | Reported | -$32.44M | (m) | (m) | (m) | -918.06% | $591.00K | -$29.29M | (m) | $21.95M | $14.03M | (m) |
|---|
| 2021-12-31 | Reported | (m) | -$394.76K | (m) | (m) | (m) | (m) | -$272.36K | (m) | (m) | (m) | (m) |
|---|